ArticleFrontiers in oncology2017

Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer.

Anastasia A Ionkina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.